Early Detection of Melanoma Progression by Quantitative Real-time RT-PCR Analysis for Multiple Melanoma Markers
-
- Arenberger Peter
- Department of Dermatovenereology, Charles University 3<sup>rd</sup> Medical Faculty
-
- Arenbergerova Monika
- Department of Dermatovenereology, Charles University 3<sup>rd</sup> Medical Faculty
-
- Vohradnikova Olga
- Department of Dermatovenereology, Charles University 3<sup>rd</sup> Medical Faculty
-
- Kremen Jaromir
- Department of Chemistry and Biochemistry, Charles University 3<sup>rd</sup> Medical Faculty
この論文をさがす
抄録
Standard screening of melanoma patients is a useful tool for predicting outcome of patients, however, an instant methodology for exact detection of subclinical disease or monitoring treatment response is under investigation.<br> Detection of circulating melanoma cells is, therefore, a possible novel promising staging method. However, inconsistent data on method sensitivity and on the predicted patient outcome has been shown repeatedly.<br> Recently, a multimarker real-time RT-PCR methodology for quantification of five melanoma markers Melan-A, gp 100, MAGE-3, MIA and tyrosinase was described by our group. In the current prospective trial, blood specimens of 65 patients with AJCC stage IIB-III cutaneous melanoma after surgery were periodically examined. In the above group, 27 % of subjects relapsed during the study. Prior to the disease progression we could observe a statistically significant tumor marker elevation in previous 0 to 9 months in all patients with clinical relapse. MAGE-3 became the most sensitive progression marker. During progression, three concordant positive markers were seen in 39 % of patients, followed by two concordant positive markers in 28 % and 1 marker in 33 %.<br> This study supports the use of a multimarker real-time RT-PCR as a disease progression predictor. The dynamic assessment of serially obtained blood specimens represents a useful method for early metastasis detection and treatment response of melanoma patients.
収録刊行物
-
- The Keio Journal of Medicine
-
The Keio Journal of Medicine 57 (1), 57-64, 2008
The Keio Journal of Medicine
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001206335367168
-
- NII論文ID
- 10024174426
-
- NII書誌ID
- AA00710216
-
- COI
- 1:STN:280:DC%2BD1c3itlOrtw%3D%3D
-
- ISSN
- 18801293
- 00229717
-
- PubMed
- 18382126
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可